CELLINI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 3.892
EU - Europa 3.192
AS - Asia 2.781
SA - Sud America 327
AF - Africa 44
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.248
Nazione #
US - Stati Uniti d'America 3.824
CN - Cina 1.175
RU - Federazione Russa 1.119
GB - Regno Unito 967
SG - Singapore 899
BR - Brasile 271
VN - Vietnam 244
IT - Italia 207
HK - Hong Kong 200
SE - Svezia 187
FR - Francia 164
FI - Finlandia 144
IE - Irlanda 137
DE - Germania 130
KR - Corea 81
UA - Ucraina 43
JP - Giappone 42
CA - Canada 40
IN - India 25
BE - Belgio 24
IQ - Iraq 16
MX - Messico 16
NL - Olanda 16
BD - Bangladesh 15
ID - Indonesia 15
PL - Polonia 15
AR - Argentina 14
ZA - Sudafrica 13
NG - Nigeria 12
PK - Pakistan 12
TR - Turchia 12
EC - Ecuador 11
ES - Italia 8
UZ - Uzbekistan 8
VE - Venezuela 8
SA - Arabia Saudita 7
AT - Austria 6
AU - Australia 6
CL - Cile 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
MA - Marocco 5
UY - Uruguay 5
LT - Lituania 4
PT - Portogallo 4
TN - Tunisia 4
AZ - Azerbaigian 3
CH - Svizzera 3
GR - Grecia 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
AM - Armenia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GF - Guiana Francese 1
GL - Groenlandia 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
LU - Lussemburgo 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.248
Città #
Southend 863
Dallas 583
Singapore 470
Ashburn 365
Moscow 361
San Jose 347
Jacksonville 325
Chandler 323
Ann Arbor 271
Woodbridge 261
Hong Kong 195
Beijing 191
Houston 159
Verona 139
Dublin 137
The Dalles 109
Jinan 93
Ho Chi Minh City 89
Shenyang 83
Nanjing 77
Wilmington 74
Lawrence 58
Princeton 58
Los Angeles 57
New York 56
Hanoi 51
Tianjin 51
Hebei 45
Tokyo 39
Columbus 36
Ningbo 35
Changsha 34
Helsinki 34
Zhengzhou 33
Nanchang 32
São Paulo 30
Buffalo 29
Haikou 29
Santa Clara 25
Seattle 25
Seoul 25
Milan 24
Brussels 23
Hangzhou 23
Lanzhou 23
Munich 22
Taiyuan 22
Jiaxing 21
Taizhou 21
San Francisco 20
Boardman 17
Fuzhou 17
Guangzhou 17
Montreal 15
Falls Church 13
Orem 13
Redondo Beach 13
Toronto 13
Brooklyn 12
Lancaster 12
London 12
Warsaw 12
Belo Horizonte 11
Boston 11
Da Nang 11
Sindelfingen 11
Abuja 10
Chennai 10
Chicago 10
Jakarta 10
Norwalk 10
Redwood City 10
Denver 9
Johannesburg 9
Elora 8
Frankfurt am Main 8
Kent 8
Mexico City 8
Perugia 8
Rio de Janeiro 8
Tashkent 8
Amsterdam 7
Auburn Hills 7
Birmingham 7
Dong Ket 7
Atlanta 6
Dearborn 6
Haiphong 6
Kemerovo 6
Council Bluffs 5
Hải Dương 5
Manchester 5
Phoenix 5
Redmond 5
Stockholm 5
Vienna 5
Baghdad 4
Cambridge 4
Can Tho 4
Dongguan 4
Totale 6.943
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 298
Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria 293
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 280
Holo-and apocystalysin from Treponema denticola: two different conformations 268
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 259
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 249
Characterization of C-S Lyase from C. diphtheriae: A Possible Target for New Antimicrobial Drugs 239
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 228
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 224
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 220
Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T 210
Astrocytes regulate the expression of Insulin-Like Growth Factor 1 Receptor (IGF1-R) in primary cortical neurons during in vitro senescence 210
S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation 209
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 204
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 201
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 198
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 197
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 196
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 195
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 195
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 191
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 189
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 189
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 183
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 180
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 178
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 176
PLP-Dependent Enzymes 176
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 170
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 169
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 164
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 163
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 162
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 161
Oligomeric state and thermal stability of apo- and holo- human ornithine δ-aminotransferase 159
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 154
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 154
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 153
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 152
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 150
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 149
Rapid profiling of disease alleles using a tunable reporter of protein misfolding 148
Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis 146
Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells 143
Role of N-acetyilaspartate (NAA) and N-acetyl-aspartyl-glutamate (NAAG) in early stage of pilocarpine induced status epilepticus in rat 140
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 140
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 134
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 132
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 129
Molecular and biochemical methods to assess the biological impact of Quantum Dots 128
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 128
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 127
Intracellular ascorbic acid enhances the DNA single-strand and toxicity induced by peroxynitrite in U937 cells 122
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 122
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 121
Molecular insights into primary hyperoxaluria Type I pathogenesis. 119
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 118
Targeting Cystalysin, a Virulence Factor ofTreponema denticola-Supported Periodontitis 113
Totale 10.305
Categoria #
all - tutte 30.839
article - articoli 29.004
book - libri 0
conference - conferenze 1.369
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 466
Totale 61.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 6 52 23
2021/2022711 60 250 102 31 19 13 9 41 23 10 29 124
2022/2023988 77 110 83 168 93 228 22 53 118 4 16 16
2023/2024406 23 35 22 44 36 66 6 32 3 27 84 28
2024/20251.335 67 85 16 215 65 49 100 43 221 105 121 248
2025/20264.025 284 190 613 511 950 317 402 200 301 257 0 0
Totale 10.305